PU.1 and Haematopoietic Cell Fate: Dosage Matters
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The ETS family transcription factor PU.1 is a key regulator of haematopoietic differentiation. Its expression is dynamically controlled throughout haematopoiesis in order to direct appropriate lineage specification. Elucidating the biological role of PU.1 has proved challenging. This paper will discuss how a range of experiments in cell lines and mutant and transgenic mouse models have enhanced our knowledge of the mechanisms by which PU.1 drives lineage-specific differentiation during haematopoiesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PU.1 is required for the development and function of myeloid and B-lymphoid cells44,45.”
From A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease (2017) · cites this paper as [45]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SPI1 encodes PU.1, a transcription factor critical for myeloid cell development and function.”
From A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease (2017) · cites this paper as [45]
The cited source says what the claim attributes to it.
In the citing paper
“Overall, CellOracle accurately simulated the myeloid lineage switching governed by Gata1 and Spi1 (refs. 15,25–27; Fig. 1g), including a relatively mild Gata1 KO phenotype in early granulocyte differentiation (Fig. 1h), which cannot be inferred from the low levels of Gata1 expression in granulocytes (Extended Data Fig. 3d).”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“Hematopoietic lineage specification is mediated by the activation of lineage-specific transcription regulators, such as PU.1 and GATA-1 (5, 52–54).”
From Histone deacetylase 1 activates PU.1 gene transcription through regulating TAF9 deacetylation and transcription factor IID assembly (2017) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532 · cited 2×
“1 knockout mice succumb to neonatal death and show a marked lack of myeloid cells, T and B cells [4, 5].”
BackgroundIdentification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic Potential
Adolfsson, J., Månsson, R., Buza-Vidas, N., Hultquist, A., Liuba, K., Jensen, C. T., Bryder, D., Yang, L., Borge, O.-J., Thoren, L. A. M., et al. (2005) · Cell · doi:10.1016/j.cell.2005.02.013 · Cited by 1,236
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130 · cited 3×
“1 mutant mice exhibit a loss of the B and T cell compartments and develop fatal septicaemia within 2 days of birth owing to a lack of mature and functional immune cells [5, 35].”
BackgroundThe macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954
Hematopoietic stem cell: self‐renewal versus differentiation
Seita, J., & Weissman, I. L. (2010) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.86 · Cited by 932 · cited 1×
“1 null mice suggest that MEPs may bypass the CMP stage and develop directly from HSCs, a hypothesis that is supported by several other studies [16–19].”
ResultRegulation of B lymphocyte and macrophage development by graded expression of PU.1
DeKoter, R. P., & Singh, H. (2000) · Science · doi:10.1126/science.288.5470.1439 · Cited by 749
Multilineage Transcriptional Priming and Determination of Alternate Hematopoietic Cell Fates
Laslo, P., Spooner, C. J., Warmflash, A., Lancki, D. W., Lee, H.-J., Sciammas, R., Gantner, B. N., Dinner, A. R., & Singh, H. (2006) · Cell · doi:10.1016/j.cell.2006.06.052 · Cited by 632
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.
Rosenbauer, F., Wagner, K., Kutok, J. L., Iwasaki, H., Le Beau, M. M., Okuno, Y., Akashi, K., Fiering, S., & Tenen, D. G. (2004) · Nature Genetics · doi:10.1038/ng1361 · Cited by 506 · cited 2×
“1 expression by 80% in mice and results in acute myeloid leukaemia (AML) and T-cell lymphoma [10, 13].”
BackgroundNegative cross-talk between hematopoietic regulators: GATA proteins repress PU.1
Zhang, P., Behre, G., Pan, J., Iwama, A., Wara-aswapati, N., Radomska, H. S., Auron, P. E., Tenen, D. G., & Sun, Z. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8705 · Cited by 459
Rekhtman, N., Radparvar, F., Evans, T., & Skoultchi, A. I. (1999) · Genes & Development · doi:10.1101/gad.13.11.1398 · Cited by 454 · cited 1×
“These two transcription factors are known to exert opposing effects on each other, and the interplay between these two master regulators is instrumental in the decision for CMPs to commit towards either the myeloid or erythroid lineage [31, 32].”
BackgroundSpi-1 is a putative oncogene in virally induced murine erythroleukaemias
Moreau-Gachelin, F., Tavitian, A., & Tambourin, P. (1988) · Nature · doi:10.1038/331277a0 · Cited by 447 · cited 3×
“1 locus and transcriptionally activates the gene, resulting in erythroblast transformation [1, 24].”
BackgroundIwasaki, H., Somoza, C., Shigematsu, H., Duprez, E. A., Iwasaki-Arai, J., Mizuno, S.-I., Arinobu, Y., Geary, K., Zhang, P., Dayaram, T., et al. (2005) · Blood · doi:10.1182/blood-2005-03-0860 · Cited by 433 · cited 10×
“1 null CMPs and GMPs from a conditional knockout mouse and assessed their capacity to form myeloid colonies in culture [12].”
BackgroundInfluentialTranscriptional control of granulocyte and monocyte development
Friedman, A. D. (2007) · Oncogene · doi:10.1038/sj.onc.1210764 · Cited by 427 · cited 1×
“1 null mice suggest that MEPs may bypass the CMP stage and develop directly from HSCs, a hypothesis that is supported by several other studies [16–19].”
ResultZhang, D.-E., Hetherington, C. J., Chen, H.-M., & Tenen, D. G. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.373-381.1994 · Cited by 411
Dahl, R., Walsh, J. C., Lancki, D., Laslo, P., Iyer, S. R., Singh, H., & Simon, M. C. (2003) · Nature Immunology · doi:10.1038/ni973 · Cited by 380 · cited 2×
“1 expression in GMPs modulates distinct regulatory networks which involve a number of lineage-specific transcription factors such as Egr-2 (early growth response-2), Gfi-1 (growth factor independent-1), and C/ebpα (CCAAT enhancer-binding protein α) [21, 38, 39].”
BackgroundPU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding
Zhang, P., Zhang, X., Iwama, A., Yu, C., Smith, K. A., Mueller, B. U., Narravula, S., Torbett, B. E., Orkin, S. H., & Tenen, D. G. (2000) · Blood · doi:10.1182/blood.v96.8.2641 · Cited by 368 · cited 3×
“Gata-1 transactivation which ordinarily promotes normal erythroid differentiation is consequently inhibited and allows erythroleukaemic transformation [33, 44].”
BackgroundDynamic regulation of PU.1 expression in multipotent hematopoietic progenitors
Nutt, S. L., Metcalf, D., D'Amico, A., Polli, M., & Wu, L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041535 · Cited by 325 · cited 8×
“This may also explain why PU.1 expression must be downregulated during erythropoiesis to allow normal production of RBCs.”
BackgroundInfluentialArinobu, Y., Mizuno, S.-I., Chong, Y., Shigematsu, H., Iino, T., Iwasaki, H., Graf, T., Mayfield, R., Chan, S., Kastner, P., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.07.004 · Cited by 309 · cited 15×
“PU.1 not only influences the myeloid-lymphoid decision of MPPs but also regulates the potential differentiation pathways to which CMPs and CLPs can commit.”
BackgroundInfluentialPU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis
Dakic, A., Metcalf, D., Di Rago, L., Mifsud, S., Wu, L., & Nutt, S. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050075 · Cited by 297 · cited 1×
“and the low numbers that were found within the bone marrow (BM) failed to generate monocytes and B and T lymphocytes [12, 14, 15].”
BackgroundHohaus, S., Petrovick, M. S., Voso, M. T., Sun, Z., Zhang, D.-E., & Tenen, D. G. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5830 · Cited by 284
Heterozygous PU.1 mutations are associated with acute myeloid leukemia
Mueller, B. U., Pabst, T., Osato, M., Asou, N., Johansen, L. M., Minden, M. D., Behre, G., Hiddemann, W., Ito, Y., & Tenen, D. G. (2002) · Blood · doi:10.1182/blood.v100.3.998 · Cited by 243
Rosenbauer, F., Owens, B. M., Yu, L., Tumang, J. R., Steidl, U., Kutok, J. L., Clayton, L. K., Wagner, K., Scheller, M., Iwasaki, H., et al. (2006) · Nature Genetics · doi:10.1038/ng1679 · Cited by 237
Spi-1/PU.1 Transgenic Mice Develop Multistep Erythroleukemias
Moreau-Gachelin, F., Wendling, F., Molina, T., Denis, N., Titeux, M., Grimber, G., Briand, P., Vainchenker, W., & Tavitian, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2453 · Cited by 189 · cited 4×
“1 in all haematopoietic lineages except T cells [11].”
BackgroundInfluentialSpooner, C. J., Cheng, J. X., Pujadas, E., Laslo, P., & Singh, H. (2009) · Immunity · doi:10.1016/j.immuni.2009.07.011 · Cited by 188 · cited 14×
“is decisive in permitting progression towards either the myeloid or lymphoid lineage [21, 22].”
BackgroundInfluentialThe role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesis
Burda, P., Laslo, P., & Stopka, T. (2010) · Leukemia · doi:10.1038/leu.2010.104 · Cited by 184 · cited 1×
“Gata-1 transactivation which ordinarily promotes normal erythroid differentiation is consequently inhibited and allows erythroleukaemic transformation [33, 44].”
BackgroundAnderson, M. K., Weiss, A. H., Hernandez-Hoyos, G., Dionne, C. J., & Rothenberg, E. V. (2002) · Immunity · doi:10.1016/s1074-7613(02)00277-7 · Cited by 182
Pop, R., Shearstone, J. R., Shen, Q., Liu, Y., Hallstrom, K., Koulnis, M., Gribnau, J., & Socolovsky, M. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000484 · Cited by 179 · cited 1×
“1 in Tavitian’s mouse line results in a maturation block with an overrepresentation of immature erythroblasts [11, 20, 23].”
BackgroundPU.1 determines the self-renewal capacity of erythroid progenitor cells
Back, J., Dierich, A., Bronn, C., Kastner, P., & Chan, S. (2004) · Blood · doi:10.1182/blood-2003-11-4089 · Cited by 123 · cited 1×
“with erythroid progenitors displaying reduced self-renewal capacity and a propensity to differentiate prematurely [6].”
BackgroundThe Ets protein Spi-B is expressed exclusively in B cells and T cells during development.
Su, G. H., Ip, H. S., Cobb, B. S., Lu, M. M., Chen, H. M., & Simon, M. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.203 · Cited by 115 · cited 1×
“1 in B cells [40, 41].”
PU.1: A crucial and versatile player in hematopoiesis and leukemia
Kastner, P., & Chan, S. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.01.026 · Cited by 101
Visualizing PU.1 activity during hematopoiesis
Back, J., Allman, D., Chan, S., & Kastner, P. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2004.12.010 · Cited by 97 · cited 16×
“PU.1 not only influences the myeloid-lymphoid decision of MPPs but also regulates the potential differentiation pathways to which CMPs and CLPs can commit.”
BackgroundInfluentialRao, G., Rekhtman, N., Cheng, G., Krasikov, T., & Skoultchi, A. I. (1997) · Oncogene · doi:10.1038/sj.onc.1200807 · Cited by 89 · cited 1×
“1 expression, are arrested at the erythroblast stage and undergo continual proliferation without differentiation [25, 26].”
BackgroundMatushansky, I., Radparvar, F., & Skoultchi, A. I. (2003) · Oncogene · doi:10.1038/sj.onc.1206484 · Cited by 88 · cited 4×
“1 directly activates expression of Cdk6 (cyclin-dependent kinase 6), a G1 phase-specific cell cycle kinase known to inhibit MEL cell differentiation [25, 30].”
BackgroundInfluentialYamada, T., Kondoh, N., Matsumoto, M., Yoshida, M., Maekawa, A., & Oikawa, T. (1997) · Blood · doi:10.1182/blood.v89.4.1383 · Cited by 87 · cited 1×
“1 in these cells has been shown to be sufficient to drive terminal differentiation in the absence of any chemical inducers [25, 27–29].”
BackgroundStarck, J., Doubeikovski, A., Sarrazin, S., Gonnet, C., Rao, G., Skoultchi, A., Godet, J., Dusanter-Fourt, I., & Morle, F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.121 · Cited by 74 · cited 1×
“1 locus and transcriptionally activates the gene, resulting in erythroblast transformation [1, 24].”
BackgroundLey, T. J., Minx, P. J., Walter, M. J., Ries, R. E., Sun, H., McLellan, M., DiPersio, J. F., Link, D. C., Tomasson, M. H., Graubert, T. A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2335924100 · Cited by 61
Suraweera, N., Meijne, E., Moody, J., Carvajal-Carmona, L. G., Yoshida, K., Pollard, P., Fitzgibbon, J., Riches, A., van Laar, T., Huiskamp, R., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208422 · Cited by 60 · cited 1×
“1 mutations and AML [45–47], suggesting that the mutations identified in the Mueller study may be linked to rare subsets of the disease.”
BackgroundFisher, R. C., Lovelock, J. D., & Scott, E. W. (1999) · Blood · doi:10.1182/blood.v94.4.1283 · Cited by 58
PU.1/Spi-B Regulation of c-rel Is Essential for Mature B Cell Survival
Hu, C., Rao, S., Ramírez‐Bergeron, D. L., Garrett‐Sinha, L. A., Gerondakis, S., Clark, M. R., & Simon, M. C. (2001) · Immunity · doi:10.1016/s1074-7613(01)00219-9 · Cited by 57 · cited 1×
“1 in B cells [40, 41].”
Vegesna, V., Takeuchi, S., Hofmann, W.-K., Ikezoe, T., Tavor, S., Krug, U., Fermin, A. C., Heaney, A., Miller, C. W., & Koeffler, H. P. (2002) · Leukemia Research · doi:10.1016/s0145-2126(01)00150-3 · Cited by 54
Houston, I. B., Kamath, M. B., Schweitzer, B. L., Chlon, T. M., & DeKoter, R. P. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.04.005 · Cited by 49 · cited 3×
“1 mutant mice exhibit a loss of the B and T cell compartments and develop fatal septicaemia within 2 days of birth owing to a lack of mature and functional immune cells [5, 35].”
BackgroundKamath, M. B., Houston, I. B., Janovski, A. J., Zhu, X., Gowrisankar, S., Jegga, A. G., & DeKoter, R. P. (2008) · Leukemia · doi:10.1038/leu.2008.67 · Cited by 41
The Complex Cartography of Stem Cell Commitment
Akashi, K., Traver, D. J., & Zon, L. I. (2005) · Cell · doi:10.1016/j.cell.2005.04.005 · Cited by 38 · cited 1×
“1 null mice suggest that MEPs may bypass the CMP stage and develop directly from HSCs, a hypothesis that is supported by several other studies [16–19].”
Choe, K. S., Ujhelly, O., Wontakal, S. N., & Skoultchi, A. I. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077727 · Cited by 36 · cited 3×
“1 directly activates expression of Cdk6 (cyclin-dependent kinase 6), a G1 phase-specific cell cycle kinase known to inhibit MEL cell differentiation [25, 30].”
BackgroundBurda, P., Curik, N., Kokavec, J., Basova, P., Mikulenkova, D., Skoultchi, A. I., Zavadil, J., & Stopka, T. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0031 · Cited by 28 · cited 1×
“These two transcription factors are known to exert opposing effects on each other, and the interplay between these two master regulators is instrumental in the decision for CMPs to commit towards either the myeloid or erythroid lineage [31, 32].”
BackgroundPapetti, M., & Skoultchi, A. I. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0145 · Cited by 26
PU.1 silencing leads to terminal differentiation of erythroleukemia cells
Atar, O., & Levi, B.-Z. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.109 · Cited by 18 · cited 2×
“1 in these cells has been shown to be sufficient to drive terminal differentiation in the absence of any chemical inducers [25, 27–29].”
Background
Research works printed but not linked: 1
- 1994, Molecular and Cellular Biology, 14, 373, 10.1128/MCB.14.1.373 · doi:10.1128/mcb.14.1.373 · Paper page
Cited by
Dissecting cell identity via network inference and in silico gene perturbation
Kamimoto, K., Stringa, B., Hoffmann, C. M., Jindal, K., Solnica-Krezel, L., & Morris, S. A. (2023) · Nature · doi:10.1038/s41586-022-05688-9 · Cited by 677
A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease
The International Genomics of Alzheimer's Project, Huang, K.-L., Initiative, T. A. D. N., Marcora, E., Pimenova, A. A., Di Narzo, A. F., Kapoor, M., Jin, S. C., Harari, O., Bertelsen, S., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4587 · Cited by 423
Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response
Pimenova, A. A., Herbinet, M., Gupta, I., Machlovi, S. I., Bowles, K. R., Marcora, E., & Goate, A. M. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105217 · Cited by 120
Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia
Seki, M., Kimura, S., Isobe, T., Yoshida, K., Ueno, H., Nakajima-Takagi, Y., Wang, C., Lin, L., Kon, A., Suzuki, H., et al. (2017) · Nature Genetics · doi:10.1038/ng.3900 · Cited by 138
Gcn5 Is Required for PU.1-Dependent IL-9 Induction in Th9 Cells
Goswami, R., & Kaplan, M. H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201496 · Cited by 100
“1 function has been described, and although it is considered a pioneer factor in cellular differentiation (21, 22), only limited work has examined the interaction of PU.”
Background
Metadata
- Authors
- Mak, K. S., Funnell, A. P. W., Pearson, R. C. M., & Crossley, M.
- Affiliations
- UNSW Sydney (AU)
- Corresponding author
- Crossley, Merlin
- Venue
- International Journal of Cell Biology
- Publisher
- Wiley
- Published
- 2011
- Volume
- 2011
- Pages
- 1-6
- ISSN
- 1687-8876 (ISSN-L)
- 1687-8884
- PMC
- PMC3154517
- OpenAlex
- W1996796247
- Cited by
- 77
- References
- 47
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 3 · 2023: 6 · 2022: 3 · 2021: 4 · 2020: 8 · 2019: 7 · 2018: 1 · 2017: 12 · 2016: 2 · 2015: 5 · 2014: 8 · 2013: 3 · 2012: 4
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- International Journal of Cell Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- PU.1, ETS transcription factors, hematopoiesis, hematopoietic differentiation, dosage effect, transcriptional regulation, mutant mouse models, transgenic mouse model
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.